#celltrion — Public Fediverse posts
Live and recent posts from across the Fediverse tagged #celltrion, aggregated by home.social.
-
Celltrion has launched its biosimilar ophthalmic drug Eydenzelt in major European markets, securing NHS tenders in the UK and expanding its presence across Europe to accelerate prescriptions, targeting a share of the $9.5 billion global market for Eylea.
#YonhapInfomax #Celltrion #Eydenzelt #Biosimilar #EuropeanMarket #EyleaSales #Economics #FinancialMarkets #Banking #Securities #Bonds #StockMarket
https://en.infomaxai.com/news/articleView.html?idxno=95705 -
Celltrion has launched its biosimilar ophthalmic drug Eydenzelt in major European markets, securing NHS tenders in the UK and expanding its presence across Europe to accelerate prescriptions, targeting a share of the $9.5 billion global market for Eylea.
#YonhapInfomax #Celltrion #Eydenzelt #Biosimilar #EuropeanMarket #EyleaSales #Economics #FinancialMarkets #Banking #Securities #Bonds #StockMarket
https://en.infomaxai.com/news/articleView.html?idxno=95705 -
Celltrion has launched its biosimilar ophthalmic drug Eydenzelt in major European markets, securing NHS tenders in the UK and expanding its presence across Europe to accelerate prescriptions, targeting a share of the $9.5 billion global market for Eylea.
#YonhapInfomax #Celltrion #Eydenzelt #Biosimilar #EuropeanMarket #EyleaSales #Economics #FinancialMarkets #Banking #Securities #Bonds #StockMarket
https://en.infomaxai.com/news/articleView.html?idxno=95705 -
Celltrion Co. advanced its global expansion strategy at BIO USA 2025 in Boston, holding over 150 meetings to strengthen partnerships and pipeline, as it targets growth into a global big pharma.
#YonhapInfomax #Celltrion #BIOUSA #GlobalPartnerships #Biosimilar #AntibodyDrugConjugate #Economics #FinancialMarkets #Banking #Securities #Bonds #StockMarket
https://en.infomaxai.com/news/articleView.html?idxno=68476 -
Celltrion explores US-based API production facilities to mitigate potential Trump administration drug tariffs, implements short-term inventory transfer and medium-term local production strategies.
#YonhapInfomax #Celltrion #DrugTariffs #APIProduction #USManufacturing #PharmaceuticalIndustry #Economics #FinancialMarkets #Banking #Securities #Bonds #StockMarket
https://en.infomaxai.com/news/articleView.html?idxno=61960 -
Celltrion's Q1 results expected to miss market estimates due to decreased sales of existing products and increased costs for US tariff preparation, despite significant year-on-year profit growth attributed to base effects.
#YonhapInfomax #Celltrion #Q1Performance #USTariffs #BiosimilarSales #OperatingProfit #Economics #FinancialMarkets #Banking #Securities #Bonds #StockMarket
https://en.infomaxai.com/news/articleView.html?idxno=61864 -
Celltrion announces plans to protect shareholder interests through share buybacks and cancellations amid global economic uncertainties, particularly focusing on upcoming US tariff policy.
#YonhapInfomax #Celltrion #ShareholderValue #USTariffPolicy #ShareBuyback #CorporateGovernance #Economics #FinancialMarkets #Banking #Securities #Bonds #StockMarket
https://en.infomaxai.com/news/articleView.html?idxno=56766